Eris Lifesciences Limited has informed the Exchange regarding 'Credit Rating Of Eris Therapeutics Limited'.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the exchanges about a credit rating update for its wholly owned subsidiary, Eris Therapeutics Limited, issued by India Ratings & Research. The filing references an India Ratings press release for the detailed rating action, but the specific rating change (upgrade, downgrade, or watch) is not disclosed in this document. The subsidiary's credit rating update is being shared in compliance with SEBI listing and disclosure requirements.
Without details of the actual rating action, investors cannot yet assess the impact on Eris Lifesciences or its subsidiary. Shareholders should look for the underlying India Ratings press release to determine whether the rating move is positive, negative, or neutral for the company's borrowing costs or financial standing.